Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial

/PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in...

Related Keywords

Amit Kumar ,Robert Wenham ,Mike Catelani ,Anixa Biosciences ,Linkedin ,Youtube ,Anixa Biosciences Inc ,Nasdaq ,Moffitt Cancer Center ,Facebook ,Moffitt Cancer ,Follicle Stimulating Hormone Receptor Mediated ,Cleveland Clinic ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Nc ,